A detailed history of Hunter Associates Investment Management LLC transactions in Mannkind Corp stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 61,700 shares of MNKD stock, worth $422,645. This represents 0.06% of its overall portfolio holdings.

Number of Shares
61,700
Previous 56,870 8.49%
Holding current value
$422,645
Previous $296,000 30.74%
% of portfolio
0.06%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$5.01 - $6.7 $24,198 - $32,361
4,830 Added 8.49%
61,700 $387,000
Q1 2024

May 01, 2024

BUY
$3.25 - $5.27 $26,000 - $42,160
8,000 Added 16.37%
56,870 $259,000
Q3 2023

Nov 09, 2023

SELL
$3.91 - $5.45 $16,422 - $22,890
-4,200 Reduced 7.91%
48,870 $202,000
Q2 2023

Aug 03, 2023

BUY
$3.72 - $4.79 $9,300 - $11,975
2,500 Added 4.94%
53,070 $214,000
Q1 2023

May 02, 2023

BUY
$3.95 - $5.63 $47,400 - $67,560
12,000 Added 31.11%
50,570 $207,000
Q4 2022

Feb 01, 2023

SELL
$3.02 - $5.37 $7,248 - $12,888
-2,400 Reduced 5.86%
38,570 $205,000
Q3 2022

Nov 02, 2022

BUY
$2.99 - $4.35 $11,063 - $16,094
3,700 Added 9.93%
40,970 $125,000
Q2 2022

Aug 10, 2022

BUY
$2.67 - $4.77 $72,810 - $130,077
27,270 Added 272.7%
37,270 $141,000
Q4 2021

Jan 27, 2022

SELL
$4.05 - $5.37 $121,500 - $161,100
-30,000 Reduced 75.0%
10,000 $44,000
Q2 2021

Aug 05, 2021

BUY
$3.61 - $5.45 $23,212 - $35,043
6,430 Added 19.15%
40,000 $218,000
Q1 2021

May 10, 2021

BUY
$3.14 - $6.14 $56,520 - $110,520
18,000 Added 115.61%
33,570 $132,000
Q4 2020

Jan 29, 2021

BUY
$1.79 - $4.04 $5,370 - $12,120
3,000 Added 23.87%
15,570 $49,000
Q2 2020

Aug 13, 2020

BUY
$0.94 - $2.21 $11,815 - $27,779
12,570 New
12,570 $22,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Hunter Associates Investment Management LLC Portfolio

Follow Hunter Associates Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.